Wilson Sonsini Goodrich & Rosati and Cooley advised Kura Oncology. Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision...
Kura Oncology’s Collaboration with Kyowa Kirin
eFishery’s $200 Million Series D Financing Round
Cooley advised eFishery on the fundraising. eFishery announced its Series D financing raising $200 million, bringing its valuation to $1.4 billion. The round was led by...